{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:50:54Z","timestamp":1790661054507,"version":"4.1.0"},"reference-count":48,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T00:00:00Z","timestamp":1604793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science Center, Poland","award":["UMO-2015\/19\/B\/NZ7\/03691."],"award-info":[{"award-number":["UMO-2015\/19\/B\/NZ7\/03691."]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Approximately 25\u201350% of people diagnosed with substance use disorder experience psychiatric disorders, and this percentage is even higher if subclinical psychopathological symptomatology is taken into consideration. \u201dDual diagnosis\u201d implies the comorbidity of two disorders (mental disorder and addiction), but in a clinical setting, numerous dual diagnoses involve multiple addictions (polysubstance use means the concurrent use of more than one psychoactive substance). Clinical observations and epidemiological studies showed that the use of stimulants in combination with other substances results in additional risks. Apart from the clinical significance of the specificity of stimulants used in combination with other substances, only non-exhaustive research on the specificity of this comorbidity has been performed to date. The aim of the study was to analyze polymorphisms of the genes (DRD4 VNTR in exon III Ex3, DRD2 rs1076560, rs1800498, rs1079597, rs6276, as well as in the PROM promoter region (rs1799732, ANKK1 Tag1A rs1800497, DAT) in a group of patients diagnosed with polysubstance use disorder, including addiction to stimulants, and the co-occurrence of specific mental disorders in a group of patients diagnosed with polysubstance use disorder, including addiction to stimulants, compared to the group of patients diagnosed with polysubstance use disorder. Methods: The study group consisted of 601 male volunteers with psychoactive substance dependence (n = 300) and non-dependent controls (n = 301). The genomic DNA was extracted from venous blood using standard procedures. Genotyping was conducted with the real-time PCR method. All computations were performed using STATISTICA 13. Results: Psychotic disorders were significantly more common in the group of males with polysubstance addiction, including addiction to stimulants, compared to the group of males with polysubstance addiction without addiction to stimulants. In our own research, different statistical significances were found in the frequency of the DRD4 Ex3 gene polymorphism: s\/s was more common in the study group. Psychotic disorders were more common in people addicted to stimulants compared to people addicted to other substances. Conclusions: In our study, psychotic disorders occurred more frequently in the study group of patients with polysubstance addiction, including addiction to stimulants, compared to the control group of patients with polysubstance addiction, but with no addiction to stimulants. Different statistical significances were found in the frequency of the DRD4 Ex3 gene polymorphism: s\/s was more common in the study group, while the l\/l genotype was less frequent in the study group. In DRD2 PROM rs 1799732, the del allele occurred more often than the ins allele in the study group. In the DRD4 Ex3 gene polymorphism, the s allele was more common in the study group, and the l allele was less frequent. In the DRD4 Ex3 gene polymorphism for the s\/s genotype, psychotic disorders and generalized anxiety were more common, while for the s\/l and l\/l genotype, they were less frequent. The DRD4 Ex3 polymorphism s alleles were more common for depressive episode, dysthymia, and psychotic disorders as well as generalized anxiety disorder. We see a clear genetic aspect here. However, we want to be careful and draw no definite conclusions.<\/jats:p>","DOI":"10.3390\/jcm9113593","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T19:03:37Z","timestamp":1604862217000},"page":"3593","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["DRD4, DRD2, DAT1, and ANKK1 Genes Polymorphisms in Patients with Dual Diagnosis of Polysubstance Addictions"],"prefix":"10.3390","volume":"9","author":[{"given":"Jolanta","family":"Masiak","sequence":"first","affiliation":[{"name":"Neurophysiological Independent Unit, Department of Psychiatry, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3285-5313","authenticated-orcid":false,"given":"Jolanta","family":"Chmielowiec","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, Collegium Medicum, University of Zielona G\u00f3ra, 65-046 Zielona G\u00f3ra, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4254-5466","authenticated-orcid":false,"given":"Krzysztof","family":"Chmielowiec","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Epidemiology, Collegium Medicum, University of Zielona G\u00f3ra, 65-046 Zielona G\u00f3ra, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2633-520X","authenticated-orcid":false,"given":"Anna","family":"Grzywacz","sequence":"additional","affiliation":[{"name":"Independent Laboratory of Health Promotion, Pomeranian Medical University in Szczecin, 70-204 Szczecin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,8]]},"reference":[{"key":"ref_1","unstructured":"Substance Abuse and Mental Health Services Administration (2020, November 05). Results from the 2018 National Survey on Drug Use and Health: Detailed tables, Available online: https:\/\/www.samhsa.gov\/data\/."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/0004867412460591","article-title":"Prevalence, correlates and comorbidity of DSM-IV cannabis use and cannabis use disorders in Australia","volume":"6","author":"Teesson","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1108\/17570971111197175","article-title":"Co-existing mental health and substance use and alcohol difficulties\u2013why do we persist with the term \u201cdual diagnosis\u201d within mental health services?","volume":"4","author":"Guest","year":"2011","journal-title":"Adv. Dual Diagn."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","article-title":"Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study","volume":"264","author":"Regier","year":"1990","journal-title":"JAMA"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2018.10.010","article-title":"Conditional probabilities of substance use disorders and associated risk factors: Progression from first use to use disorder on alcohol, cannabis, stimulants, sedatives and opioids","volume":"194","author":"Marel","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"ref_6","unstructured":"European Monitoring Centre for Drugs, & Drug Addiction (2002). Two Thousand and Two Annual Report on the State of the Drugs Problem in the European Union and Norway, Office for Official Publications of the European Communities."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Delgadillo, J., and Kay-Lambkin, F. (2016). Closing the science-practice gap: Introduction to the special issue on psychological interventions for comorbid addictions and mental health problems. Adv. Dual Diagn., 9.","DOI":"10.1108\/ADD-06-2016-0013"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ps.201700194","article-title":"A change in perspective: From dual diagnosis to multimorbidity","volume":"69","author":"Bhalla","year":"2018","journal-title":"Psychiatr. Serv."},{"key":"ref_9","unstructured":"Torrens, M., Mestre-Pint\u00f3, J.I., and Domingo-Salvany, A. (2015). Comorbidity of Substance Use and Mental Disorders in Europe, Publication Office of the European Union."},{"key":"ref_10","first-page":"53","article-title":"Dual diagnosis competencies: A systematic review of staff training literature","volume":"7","author":"Petrakis","year":"2018","journal-title":"Addict. Behav. Rep."},{"key":"ref_11","unstructured":"Substance Abuse and Mental Health Services Administration (2014). The DAWN Report: Emergency Department Visits Involving Methamphet- Amine: 2007 to 2011."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.drugalcdep.2018.06.001","article-title":"Socio-cognitive functioning in stimulant polysubstance users","volume":"190","author":"Kroll","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.addbeh.2013.10.021","article-title":"Rate of progression from first use to dependence on cocaine or opioids: A cross-substance examination of associated demographic, psychiatric, and childhood risk factors","volume":"39","author":"Sartor","year":"2014","journal-title":"Addict. Behav."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41386-019-0389-5","article-title":"How genome-wide association studies (GWAS) made traditional candidate gene studies obsolete","volume":"44","author":"Duncan","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neuropharm.2004.07.029","article-title":"Molecular genetic underpinnings of human substance abuse vulnerability: Likely contributions to understanding addiction as a mnemonic process","volume":"47","author":"Uhl","year":"2004","journal-title":"Neuropharmacology"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Suchanecka, A., Chmielowiec, J., Chmielowiec, K., Masiak, J., Sipak-Szmigiel, O., Sznabowicz, M., Czarny, W., Micha\u0142owska-Sawczyn, M., Trybek, G., and Grzywacz, A. (2020). Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder. Brain Sci., 10.","DOI":"10.3390\/brainsci10050262"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Suchanecka, A., Chmielowiec, K., Chmielowiec, J., Trybek, G., Masiak, J., Micha\u0142owska-Sawczyn, M., Nowicka, R., Grocholewicz, K., and Grzywacz, A. (2020). Vitamin D Receptor Gene Polymorphisms and Cigarette Smoking Impact on Oral Health: A Case-Control Study. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17093192"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.26444\/aaem\/119940","article-title":"Significant association of DRD2 and ANKK1 genes with rural heroin dependence and relapse in men","volume":"27","author":"Lachowicz","year":"2020","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, C.Y., Mao, X., and Wei, L. (2008). Genes and (common) pathways underlying drug addiction. PLoS Comput. Biol., 4.","DOI":"10.1371\/journal.pcbi.0040002"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMra1511480","article-title":"Neurobiologic advances from the brain disease model of addiction","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/358149a0","article-title":"Multiple dopamine D4 receptor variants in the human population","volume":"358","author":"Wu","year":"1992","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1046\/j.1471-4159.1995.65031157.x","article-title":"Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants","volume":"65","author":"Asghari","year":"1995","journal-title":"J. Neurochem."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Chmielowiec, J., Chmielowiec, K., Suchanecka, I., Mroczek, B., Trybek, G., Ma\u0142ecka, I., and Grzywacz, A. (2018). Associations between the Dopamine D4 Receptor and DAT1 Dopamine Transporter Genes Polymorphisms and Personality Traits in Addicted Patients. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15102076"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ray, L.A., Bryan, A., MacKillop, J., McGeary, J., Hesterberg, K., and Hutchison, K.E. (2008). The dopamine D4 receptor (DRD4) gene exon III polymorphism, problematic alcohol use, and novelty seeking: Direct and mediated genetic effects. Addict. Biol., 14.","DOI":"10.1111\/j.1369-1600.2008.00120.x"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"144267","DOI":"10.1016\/j.gene.2019.144267","article-title":"Association of the DRD4 exon III and 5-HTTLPR VNTR polymorphisms with substance abuse in Jordanian Arab population","volume":"733","author":"Alshudaifat","year":"2020","journal-title":"Gene"},{"key":"ref_26","first-page":"1013","article-title":"Case-control analysis of DRD2 gene polymorphisms in drug addicted patients","volume":"6","author":"Samochowiec","year":"2018","journal-title":"Psychiatr. Pol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02791072.2000.10736099","article-title":"Reward deficiency syndrome: A biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors","volume":"32","author":"Blum","year":"2000","journal-title":"J. Psychoact. Drugs"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1914940","DOI":"10.1001\/jamanetworkopen.2019.14940","article-title":"Assessment of the association of D2 dopamine receptor gene and reported allele frequencies with alcohol use disorders: A systematic review and meta-analysis","volume":"2","author":"Jung","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1073\/pnas.95.13.7731","article-title":"Prominence of the dopamine D2 short isoform in dopaminergic pathways","volume":"95","author":"Khan","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.neulet.2006.10.064","article-title":"Association analysis of the dopamine receptor D2 (DRD2) SNP rs1076560 in alcoholic patients","volume":"412","author":"Sasabe","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/npp.2010.208","article-title":"Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse","volume":"36","author":"Moyer","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/ahg.12046","article-title":"The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction","volume":"78","author":"Clarke","year":"2013","journal-title":"Ann. Hum. Genet."},{"key":"ref_33","unstructured":"Gordon, A. (2010). Comorbidity of Mental Disorders and Substance Use: A Brief Guide for the Primary Care Clinician."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"261","DOI":"10.12740\/PP\/68472","article-title":"The reasons for use of cannabinoids and stimulants in patients with schizophrenia","volume":"52","author":"Simonienko","year":"2018","journal-title":"Psychiatr. Pol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1007\/s00213-019-05298-w","article-title":"A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia","volume":"236","author":"Alexander","year":"2019","journal-title":"Psychopharmacology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0006-3223(01)01134-9","article-title":"A neurobiological basis for substance abuse comorbidity in schizophrenia","volume":"50","author":"Chambers","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.schres.2017.04.016","article-title":"The link between schizophrenia and substance use disorder: A unifying hypothesis","volume":"194","author":"Khokhar","year":"2018","journal-title":"Schizophr. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.alcohol.2009.05.002","article-title":"Affective temperaments in alcoholic patients","volume":"43","author":"Pacini","year":"2009","journal-title":"Alcohol"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jad.2009.01.007","article-title":"Affective temperaments in heroin addiction","volume":"117","author":"Maremmani","year":"2009","journal-title":"J. Affect. Disord."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jad.2003.10.014","article-title":"Proposal for a bipolar-stimulant spectrum: Temperament, diagnostic validation and therapeutic outcomes with mood stabilizers","volume":"85","author":"Camacho","year":"2005","journal-title":"J. Affect. Disord."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2007.03.015","article-title":"Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: Clinical observations and a proposed pathophysiologic model","volume":"106","author":"Maremmani","year":"2008","journal-title":"J. Affect. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/ADT.0b013e3181f954f2","article-title":"Cocaine Abuse in 448 Alcoholics: Evidence for a Bipolar Connection","volume":"9","author":"Pacini","year":"2010","journal-title":"Addict Disord Their Treat."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1097\/01.yic.0000405799.57088.d9","article-title":"Pattern of cocaine consumption in a sample of italian alcoholics","volume":"26","author":"Vitali","year":"2011","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_44","first-page":"36","article-title":"Current use of cannabis and past use of heroin as predictors of alcohol and concomitant cocaine use disorder","volume":"22","author":"Maremmani","year":"2015","journal-title":"Alcologia"},{"key":"ref_45","first-page":"23","article-title":"Possible trajectories of addictions: The role of bipolar spectrum","volume":"18","author":"Maremmani","year":"2016","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"key":"ref_46","first-page":"7","article-title":"Alcohol, benzodiazepines and other drugs use in heroin addicts treated with methadone. Polyabuse or undermedication?","volume":"1","author":"Maremmani","year":"1999","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/alcalc\/agv028","article-title":"Former heroin-dependent alcohol use disorder patients. Prevalence, addiction history and clinical features","volume":"50","author":"Pacini","year":"2015","journal-title":"Alcohol Alcohol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neulet.2006.01.020","article-title":"Association between dopamine D4 receptor (DRD4) exon III polymorphism and neuroticism in the Japanese population","volume":"398","author":"Tochigi","year":"2006","journal-title":"Neurosci. Lett."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/11\/3593\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:30:41Z","timestamp":1760178641000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/11\/3593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,8]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["jcm9113593"],"URL":"https:\/\/doi.org\/10.3390\/jcm9113593","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,8]]}}}